Arvinas, Inc. SEC filings ARVN
Arvinas, Inc. has 602 filings in SEC EDGAR's recent list, going back to Oct 23, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2024 | — |
| CT ORDER | Filing | May 26, 2021 | — |
| CT ORDER | Filing | May 26, 2021 | — |
| EFFECT | Filing | Oct 10, 2019 | — |
| EFFECT | Filing | Oct 10, 2019 | — |
| CORRESP | Letter to the SEC | Oct 8, 2019 | — |
| CORRESP | Letter to the SEC | Oct 8, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2019 | — |
| D | Filing | Jul 19, 2019 | — |
| CT ORDER | Filing | May 3, 2019 | — |
| CT ORDER | Filing | Sep 27, 2018 | — |
| EFFECT | Filing | Sep 26, 2018 | — |
| CERT | Filing | Sep 26, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| 8-A12B | Filing | Sep 21, 2018 | — |
| CORRESP | Letter to the SEC | Sep 4, 2018 | — |
| CORRESP | Letter to the SEC | Aug 30, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2018 | — |
| DRSLTR | Filing | Aug 2, 2018 | — |
| DRS/A | Filing | Aug 2, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2018 | — |
| DRS | Filing | Jun 22, 2018 | — |
| D | Filing | Apr 5, 2018 | — |
| D | Filing | Oct 23, 2015 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1655759
- Former names
- ARVINAS INC. (until Oct 10, 2018); ARVINAS HOLDING COMPANY, LLC (until Sep 28, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.